S09279 Summary:
| BILL NO | S09279 |
| SAME AS | SAME AS A03283-B |
| SPONSOR | GIANARIS |
| COSPNSR | |
| MLTSPNSR | |
| Add Art 32-B §3230, Pub Health L | |
| Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health; requires the department of health to utilize generally accepted industry standards and take into consideration recommendations and protocols set by the international gene synthesis consortium protocols in formulating such rules and regulations. | |
S09279 Text:
Go to topSTATE OF NEW YORK ________________________________________________________________________ 9279 IN SENATE February 24, 2026 ___________ Introduced by Sen. GIANARIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to the operation of gene synthesis providers and manufacturers of gene synthesis equipment The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Short title. This act shall be known and may be cited as 2 the "bioterrorism prevention act". 3 § 2. The public health law is amended by adding a new article 32-B to 4 read as follows: 5 ARTICLE 32-B 6 GENE SYNTHESIS LABS 7 Section 3230. Operation of gene synthesis providers and manufacturers of 8 gene synthesis equipment. 9 § 3230. Operation of gene synthesis providers and manufacturers of 10 gene synthesis equipment. Any gene synthesis provider or manufacturer 11 of laboratory equipment intended for use by a gene synthesis provider 12 shall operate in accordance with rules and regulations issued by the 13 department. The department shall utilize generally accepted industry 14 standards and take into consideration recommendations and protocols set 15 by the international gene synthesis consortium and/or other similar 16 nationally or internationally recognized relevant organizations to draft 17 such rules and regulations. For the purpose of this section, "gene 18 synthesis provider" shall mean any entity that synthesizes and distrib- 19 utes synthetic nucleic acids to a customer or to a distributor. 20 § 3. This act shall take effect immediately. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD04229-05-6